Deciphera Pharmaceuticals commences Phase I trial of DCC-3014 for advanced malignancies

Clinical-stage biopharmaceutical firm Deciphera Pharmaceuticals has commenced a Phase I clinical trial of DCC-3014 for the treatment of patients with advanced malignancies.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news